NCT05122429 is a NA clinical trial of e-Health Treatment in Depressive Symptoms, sponsored by Stony Brook University.

Who is sponsoring NCT05122429?

NCT05122429 is sponsored by Stony Brook University.

What drugs are being tested in NCT05122429?

Interventions in NCT05122429: e-Health Treatment.

What condition does NCT05122429 study?

NCT05122429 studies Depressive Symptoms, Anxiety, Stress, Impairment.

Is NCT05122429 still recruiting?

NCT05122429 is currently completed. Last updated 16 November 2021.

Last reviewed 2021-11-16 · How we verify

NCT05122429

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Asynchronous Techniques for the Delivery of Empirically Supported Psychotherapies

Completed NA Last updated 16 November 2021

What this trial tests

NA trial testing e-Health Treatment in Depressive Symptoms in 145 participants. Completed in 17 December 2018.

Timeline

6 November 2017

Primary endpoint
17 December 2018

17 December 2018

Quick facts

Lead sponsor	Stony Brook University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	145
Start date	6 November 2017
Primary completion	17 December 2018
Estimated completion	17 December 2018
Sites	1 location across United States

Drugs / interventions tested

e-Health Treatment

Conditions studied

Depressive Symptoms — all drugs for Depressive Symptoms →
Anxiety — all drugs for Anxiety →
Stress — all drugs for Stress →
Impairment — all drugs for Impairment →

Sponsor

Stony Brook University

Who can join

18 and older, any sex, with Depressive Symptoms or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to test the feasibility, acceptability and efficacy of methods for delivering mental health support when real-time communication is not possible (e.g. on long duration space flights where communication lags of up to 45 minutes are anticipated). The investigators hypothesize that the two enhanced treatment conditions (i.e., those with therapist support) will outperform the online self-management program without support. The investigators also predict that outcomes for the two enhanced conditions will be comparable to those reported in the literature for in-person psychotherapy programs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Conceptual Invariance, Trajectories, and Outcome Associations of Working Alliance in Unguided and Guided Internet-Based Psychological Interventions: Secondary Analysis of a Randomized Controlled Trial.
Luo X, Bugatti M, Molina L, Tilley JL, et al · · 2022 · cited 5× · PMID 35727626 · DOI 10.2196/35496

Verify or expand the search:

Other recruiting trials for Depressive Symptoms

Currently open trials in the same condition.

NCT07299903 — IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression · NA · recruiting
NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section · recruiting
NCT07216326 — Our Voices Matter: Intervention for Depression in Youth · NA · recruiting

Other Stony Brook University trials

Trials by the same sponsor.

NCT07478250 — First Responder Safety Training (FiRST) · NA · not yet recruiting
NCT07076342 — The Role of mGluR5 in CBT-I · Phase 4 · recruiting
NCT07009691 — Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS · NA · recruiting
NCT07114900 — Randomized Controlled Physical Activity App Intervention for Black Women · Phase 3 · active not recruiting
NCT05245227 — Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05122429 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stony Brook University
Last refreshed: 16 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05122429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing